Closed CDC-RFA-IP21-2105 CFDA 93.268 Discretionary

Human Papillomavirus (HPV) Roundtable: Supporting a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination

Posted by Centers for Disease Control - NCIRD

Opportunity snapshot. This Grants.gov announcement — Human Papillomavirus (HPV) Roundtable: Supporting a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination — is cataloged under number CDC-RFA-IP21-2105 and tied to CFDA assistance listing 93.268, posted by Centers for Disease Control - NCIRD. Grants.gov currently shows the opportunity as closed, first posted on January 12, 2021 and last updated on January 20, 2021. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Varies by applicant. The agency has projected $2.3 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $2.3 million estimated pool, the average award works out to roughly $2.3 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on March 22, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Varies by applicant

Close Date

March 22, 2021

Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.

Posted

January 12, 2021

Est. Total Funding

$2,250,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The purpose of this cooperative agreement is to: (1). Advance a national network of cancer prevention organizations, immunization partners, and other stakeholders by creating and supporting a planning committee that prioritizes network activities, updates and disseminates educational resources, and expands the diversity of organizations represented within the network that positively impact HPV vaccination rates; (2). Convene a national meeting of network members to provide technical assistance and catalyze their support of efforts to increase HPV vaccine uptake; and (3). Create and support task groups to address priority areas identified by the national network, initiate high-priority pilot projects to reduce barriers to HPV vaccine uptake, and share lessons learned. By working toward these goals, the network can provide channels of education, outreach, and training structured for the public and healthcare providers. The network, through its engagement and coordination with stakeholders, will be equipped to increase public and provider understanding of the burden of HPV-associated cancers that can be prevented by HPV vaccination and to accelerate the full implementation of HPV vaccination to prevent HPV-associated cancers.

Eligibility

99

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Jonathan Hill<br/>hws1@cdc.gov

Key Dates

Posted January 12, 2021
Close Date March 22, 2021
Archive Date April 21, 2021
Last Updated January 20, 2021

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Human Papillomavirus (HPV) Roundtable: Supporting a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination", offered by Centers for Disease Control - NCIRD. It is associated with CFDA program 93.268. The purpose of this cooperative agreement is to: (1). Advance a national network of cancer prevention organizations, immunization partners, and other stakeholders by creating and supporting a planning...
Is this opportunity still open?
No, this opportunity is closed. It closed on March 22, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $2,250,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial